Detalhe da pesquisa
1.
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
Cell
; 184(9): 2384-2393.e12, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794143
2.
Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
J Immunol
; 206(11): 2614-2622, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980583
3.
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.
Mol Ther
; 30(1): 311-326, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547465
4.
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Clin Infect Dis
; 75(1): e653-e661, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35079775
5.
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein.
Antibodies (Basel)
; 13(1)2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247569
6.
Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice.
Front Immunol
; 14: 1231274, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37753087
7.
Determinants of species-specific utilization of ACE2 by human and animal coronaviruses.
Commun Biol
; 6(1): 1051, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848611
8.
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.
Front Immunol
; 14: 1170759, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180152
9.
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection.
Front Pediatr
; 11: 1020865, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051428
10.
Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.
Antiviral Res
; 203: 105343, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598779
11.
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults.
Front Immunol
; 13: 882918, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35958601
12.
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
EBioMedicine
; 75: 103761, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929493
13.
High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection.
Nat Commun
; 13(1): 7315, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36437276
14.
Robust and durable serological response following pediatric SARS-CoV-2 infection.
Nat Commun
; 13(1): 128, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013206
15.
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection.
Nat Commun
; 12(1): 1726, 2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741941